Loading chat...
AL SB273
Bill
Status
4/1/2025
Primary Sponsor
April Weaver
Click for details
AI Summary
SB273 Summary
-
Classifies Delta-8, Delta-9, and Delta-10 THC as Schedule I controlled substances, while exempting only nonpsychoactive cannabinoids (CBD, CBG) derived from hemp.
-
Restricts sale of consumable hemp products containing nonpsychoactive cannabinoids (tablets, capsules, gummies, topicals) to licensed pharmacies certified by the Alabama State Board of Pharmacy, effective January 1, 2026.
-
Requires Department of Agriculture and Industries to establish seed-to-sale tracking system and implement testing protocols for hemp cultivation, processing, and products to ensure safety and quality consistency.
-
Mandates laboratory testing for cannabinoid content, pesticides, heavy metals, microbial contamination, and other contaminants prior to product sale, with costs borne by cultivators and processors.
-
Repeals existing ban on selling psychoactive cannabinoids to minors and becomes effective July 1, 2025.
Legislative Description
Controlled substances; regulate sale of nonpsychoactive consumable hemp products by Agriculture Department; require sale of products only in pharmacies; add psychoactive derivatives of hemp as Schedule I drug
Crimes & Offenses
Last Action
Currently Indefinitely Postponed
5/6/2025